The evaluation of drugs by FDA has always been the focus of pharmaceutical research all over the world, and the approval of NME (New molecular entity) to market is the […]
Pre-doxercalciferol is a precursor of doxercalciferol, a drug used for the treatment of secondary hyperparathyroidism and metabolic bone disease. Doxercalferol, the active ingredient of Hectorol®, is a synthetic vitamin D2 analog. […]
Eribulin is an analog of halichondrin B, which is a macrocycle, a polyether, a polycyclic ether, a cyclic ketone, a primary amine compound, and a cyclic ketal. Eribulin is […]
Benzimidazolium is a benzo heterocycle compound containing two nitrogen atoms. Benzimidazole has a special chemical structure which can form hydrogen bonds with enzymes and receptors in organisms, coordinate with metal […]
Phosphate is an important part of nucleic acid, a large number of which exists in the human body, it is a kind of harmless endogenous substances, which can help drugs […]
ASCO 2019, the largest, highest academic and most authoritative clinical oncology conference in the world, was held in Chicago from May 31 to June 4. At the ASCO annual meeting, […]
The prognosis of patients with early lung cancer is better, but many patients with lung cancer are diagnosed with advanced stage, and the overall five-year survival rate is only about […]
With the development of scientific and technological means, there are many ways to obtain drugs, including separation from plants and other natural sources, synthetic chemistry, combinatorial chemistry and molecular modeling. […]
This paper takes an inventory of the latest clinical trials in the field of Alzheimer’s disease and liver cancer in the world as of May 6, 2019. The data source […]
Temsirolimus was developed by Hara Wyeth Pharmaceuticals and was approved for listing by FDA in May 2007 for the treatment of renal cell carcinoma. The drug is the first antineoplastic […]